UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3025% above fair value
$591.17−2.14 (-0.36%)
Close on Nov 13, 2026Market cap $25.36BP/E 22.3Yield –
United Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
United Therapeutics's enterprise value was $22.76B on Nov 11, 2026, against $18.08B a year earlier. Over the last 5 years it ranged from $5.57B to $22.96B, with a median of $10.06B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $22.76B | +25.5% |
| 2025 | Dec 31, 2025 | $18.14B | +46.1% |
| 2024 | Dec 31, 2024 | $12.42B | +66.5% |
| 2023 | Dec 29, 2023 | $7.46B | -25.9% |
| 2022 | Dec 30, 2022 | $10.06B | +30.1% |
| 2021 | Dec 31, 2021 | $7.73B | +49.6% |
| 2020 | Dec 31, 2020 | $5.17B | +125.1% |
| 2019 | Dec 31, 2019 | $2.30B | -34.6% |
| 2018 | Dec 31, 2018 | $3.51B | -32.3% |
| 2017 | Dec 29, 2017 | $5.18B | +0.3% |
| 2016 | Dec 30, 2016 | $5.17B | -18.9% |
| 2015 | Dec 31, 2015 | $6.37B | +12.9% |
| 2014 | Dec 31, 2014 | $5.65B | +4.1% |
| 2013 | Dec 31, 2013 | $5.42B | +113.4% |
| 2012 | Dec 31, 2012 | $2.54B | +2.4% |
| 2011 | Dec 30, 2011 | $2.48B | -26.6% |
| 2010 | Dec 31, 2010 | $3.38B | +48.1% |
| 2009 | Dec 31, 2009 | $2.28B | – |
See a number that looks wrong?